Buerger disease

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:36258OMIM:211480I73.1
Who is this for?
Show terms as
3Active trials40Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Buerger disease, also known as thromboangiitis obliterans (TAO), is a rare but serious disease that affects the blood vessels in the arms and legs. In this condition, the small and medium-sized arteries and veins become inflamed and blocked by blood clots. This cuts off blood flow to the hands, feet, fingers, and toes. Over time, the lack of blood flow can cause severe pain, open sores, and in the worst cases, tissue death (gangrene) that may require amputation. The most important known cause of Buerger disease is tobacco use — including cigarettes, cigars, chewing tobacco, and even heavy secondhand smoke exposure. The disease almost always occurs in people who use tobacco, and quitting tobacco is the single most important step in slowing or stopping the disease. It is not a typical genetic disease, though some people may be more susceptible than others. Symptoms usually start in young adults, often before age 45. People may notice pain in their feet or hands during activity, cold or bluish fingers or toes, and painful sores that do not heal. There is no cure, but stopping all tobacco use can halt disease progression. Treatments focus on improving blood flow, managing pain, and preventing amputation.

Also known as:

Key symptoms:

Pain in the feet, legs, hands, or arms during walking or activityPain at rest in the fingers or toes, especially at nightCold, numb, or tingling fingers and toesSkin color changes — fingers or toes turning pale, bluish, or reddishPainful open sores or ulcers on fingers or toes that do not healTissue death (gangrene) in severe casesSwollen, tender veins just under the skin (superficial phlebitis)Weak or absent pulse in the wrist or footSensitivity to cold temperaturesRaynaud's phenomenon — fingers or toes turning white or blue in the cold

Clinical phenotype terms (17)— hover any for plain English
Arterial thrombosisHP:0004420AcrocyanosisHP:0001063Intermittent claudicationHP:0004417Raynaud phenomenonHP:0030880Digital ischemiaHP:0033402Livedo reticularisHP:0033505Superficial thrombophlebitisHP:0002638AcroparesthesiaHP:0031006InsomniaHP:0100785Arterial occlusionHP:0025324
Inheritance

Multifactorial

Caused by a mix of several genes and environmental factors

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

4 events
Oct 2025A First in Human Single Ascending Dose (SAD) Study of ATI-1013 in Healthy Smokers

Antidote Therapeutics, Inc — PHASE1

TrialRECRUITING
Jun 2025Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L)

Beijing Northland Biotech. Co., Ltd.

TrialENROLLING BY INVITATION
Jan 2025Evaluation of Botulinum TOXin Type a in the Treatment of Buerger's Disease

University Hospital, Toulouse — PHASE3

TrialNOT YET RECRUITING
Jan 2024Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease

Cell Biopeutics Resources Sdn Bhd — PHASE4

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Buerger disease.

3 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

3 recruitingView all trials with filters →
Phase 41 trial
Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease
Phase 4
Actively Recruiting
PI: Hanafiah Harunarashid, MS (National University of Malaysia) · Sites: Kuala Lumpur · Age: 1865 yrs
Phase 11 trial
A First in Human Single Ascending Dose (SAD) Study of ATI-1013 in Healthy Smokers
Phase 1
Actively Recruiting
PI: Matthew Kalnik, PhD (Antidote Therapeutics, Inc) · Sites: Overland Park, Kansas · Age: 2359 yrs
Other1 trial
Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L)
Enrolling by Invitation
· Sites: Beijing, Beijing Municipality; Chifeng, Neimenggu +3 more · Age: 2085 yrs

Specialists

Showing 25 of 40View all specialists →
DD
Dr Santanu Dutta
Specialist
PI on 1 active trial9 Buerger disease publications
DK
Dr Murali Krishna
Specialist
PI on 1 active trial
DP
Dr Rajiv Parakh
Specialist
PI on 1 active trial
DA
Dr Alfred Augustine
Specialist
PI on 1 active trial
DR
Dr Radhakrishnan R
Specialist
PI on 1 active trial
DD
Dr Anita Dhar
Specialist
PI on 1 active trial
DD
Dr Sanjay Desai
Specialist
PI on 1 active trial
DM
Dr Rajkumar M
Specialist
PI on 1 active trial
DC
Dr Anirban Chatterjee
Specialist
PI on 1 active trial
DT
Dr Vidyasagaran T
Specialist
PI on 1 active trial
HM
Hanafiah Harunarashid, MS
Specialist
PI on 1 active trial
OC
Olivier COTTENCIN
Specialist
PI on 1 active trial
CD
Christophe Seinturier, Doctor
Specialist
PI on 1 active trial
JM
Joaquin De Haro, MD,PhD
Specialist
PI on 1 active trial
NE
Natalie S Evans
Specialist
1 Buerger disease publication
MS
Michela V R Starace
Specialist
1 Buerger disease publication
AA
Aurora Alessandrini
Specialist
1 Buerger disease publication
BP
Bianca Maria Piraccini
Specialist
1 Buerger disease publication
RS
Ramin Shekouhi
Specialist
1 Buerger disease publication
FY
Farina Mohamad Yusoff
Specialist
2 Buerger disease publications
ER
Elizabeth V Ratchford
LUTHERVILLE, MD
Specialist
1 Buerger disease publication
MK
Masato Kajikawa
Specialist
2 Buerger disease publications
YH
Yukihito Higashi
Specialist
2 Buerger disease publications
JM
Julie Malloizel-Delaunay, MD
Specialist
PI on 3 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Buerger disease.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Buerger diseaseForum →

No community posts yet. Be the first to share your experience with Buerger disease.

Start the conversation →

Latest news about Buerger disease

Disease timeline:

New recruiting trial: Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease

A new clinical trial is recruiting patients for Buerger disease

New recruiting trial: A First in Human Single Ascending Dose (SAD) Study of ATI-1013 in Healthy Smokers

A new clinical trial is recruiting patients for Buerger disease

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What is the best plan to help me quit all tobacco, and which medications are safe for me to use?,How advanced is my disease, and which blood vessels are most affected?,What warning signs should make me go to the emergency room right away?,Are there any medications or procedures that could improve blood flow to my hands and feet?,How do I care for the sores on my fingers or toes at home, and when should I see a wound care specialist?,What lifestyle changes beyond quitting tobacco can help slow the disease?,Is there a clinical trial or newer treatment I might be eligible for?

Common questions about Buerger disease

What is Buerger disease?

Buerger disease, also known as thromboangiitis obliterans (TAO), is a rare but serious disease that affects the blood vessels in the arms and legs. In this condition, the small and medium-sized arteries and veins become inflamed and blocked by blood clots. This cuts off blood flow to the hands, feet, fingers, and toes. Over time, the lack of blood flow can cause severe pain, open sores, and in the worst cases, tissue death (gangrene) that may require amputation. The most important known cause of Buerger disease is tobacco use — including cigarettes, cigars, chewing tobacco, and even heavy sec

How is Buerger disease inherited?

Buerger disease follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Buerger disease typically begin?

Typical onset of Buerger disease is adult. Age of onset can vary across affected individuals.

Are there clinical trials for Buerger disease?

Yes — 3 recruiting clinical trials are currently listed for Buerger disease on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Buerger disease?

25 specialists and care centers treating Buerger disease are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.